Influencing factors for the homing ability of mesenchymal stem cells in end-stage liver disease and optimization measures
- VernacularTitle:终末期肝病间充质干细胞归巢能力的影响因素及优化措施
- Author:
Yuxin LIU
1
;
Liaoyun ZHANG
1
Author Information
- Publication Type:Review
- Keywords: End Stage Liver Disease; Mesenchymal Stem Cells; Homing
- From: Journal of Clinical Hepatology 2025;41(3):561-567
- CountryChina
- Language:Chinese
- Abstract: Mesenchymal stem cells （MSCs） have emerged as a promising cellular therapy for end-stage liver disease （ESLD） due to their robust self-regenerative， paracrine， and immunomodulatory characteristics， providing new directions for the treatment of advanced liver disease. However， the clinical application of MSCs is significantly limited by the fact that only a small number of MSCs can reach the liver due to massive apoptosis or necrosis during the homing process caused by the influence of the complex microenvironment （inflammation， oxidative stress， and hypoxia） of the injured liver and the fact that a substantial proportion of MSCs become trapped in the pulmonary capillaries following intravenous administration with a lack of sufficient homing receptors or adhesion molecules. Various strategies have been developed to optimize the proliferation， migration， and homing abilities of MSCs， including preconditioning， gene modification， and nanoencapsulation technology. This article elaborates on the influencing factors for the homing ability of MSCs， the strategies to optimize their homing in ESLD， and the mechanism of the homing of MSCs， in order to improve cell transplantation efficiency， promote liver repair and regeneration， and pave the way for the application of MSCs in the treatment of ESLD.
